Your browser doesn't support javascript.
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology.
Khera, Amit; Baum, Seth J; Gluckman, Ty J; Gulati, Martha; Martin, Seth S; Michos, Erin D; Navar, Ann Marie; Taub, Pam R; Toth, Peter P; Virani, Salim S; Wong, Nathan D; Shapiro, Michael D.
  • Khera A; Division of Cardiology, UT Southwestern Medical Center, Dallas, TX, USA.
  • Baum SJ; Florida Atlantic University, Department of Integrated Medical Sciences, Boca Raton, FL, USA.
  • Gluckman TJ; Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR, USA.
  • Gulati M; Division of Cardiology, University of Arizona College of Medicine- Phoenix, Phoenix, AZ, USA.
  • Martin SS; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Michos ED; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Navar AM; Division of Cardiology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
  • Taub PR; Division of Cardiovascular Medicine, UC San Diego School of Medicine, La Jolla, CA, USA.
  • Toth PP; CGH Medical Center, Sterling, IL, Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Virani SS; Division of Cardiology, Baylor College of Medicine and Michael E. DeBakey VA Medical Center, Houston, TX, USA.
  • Wong ND; Division of Cardiology, UC Irvine School of Medicine, Irvine, CA, USA.
  • Shapiro MD; Section of Cardiovascular Medicine, Wake Forest School of Medicine, Winston Salem, NC, USA.
Am J Prev Cardiol ; 1: 100009, 2020 Mar.
Article in English | MEDLINE | ID: covidwho-155113
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has consumed our healthcare system, with immediate resource focus on the management of high numbers of critically ill patients. Those that fare poorly with COVID-19 infection more commonly have cardiovascular disease (CVD), hypertension and diabetes. There are also several other conditions that raise concern for the welfare of patients with and at high risk for CVD during this pandemic. Traditional ambulatory care is disrupted and many patients are delaying or deferring necessary care, including preventive care. New impediments to medication access and adherence have arisen. Social distancing measures can increase social isolation and alter physical activity and nutrition patterns. Virtually all facility based cardiac rehabilitation programs have temporarily closed. If not promptly addressed, these changes may result in delayed waves of vulnerable patients presenting for urgent and preventable CVD events. Here, we provide several recommendations to mitigate the adverse effects of these disruptions in outpatient care. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers should be continued in patients already taking these medications. Where possible, it is strongly preferred to continue visits via telehealth, and patients should be counselled about promptly reporting new symptoms. Barriers to medication access should be reviewed with patients at every contact, with implementation of strategies to ensure ongoing provision of medications. Team-based care should be leveraged to enhance the continuity of care and adherence to lifestyle recommendations. Patient encounters should include discussion of safe physical activity options and access to healthy food choices. Implementation of adaptive strategies for cardiac rehabilitation is recommended, including home based cardiac rehab, to ensure continuity of this essential service. While the practical implementation of these strategies will vary by local situation, there are a broad range of strategies available to ensure ongoing continuity of care and health preservation for those at higher risk of CVD during the COVID-19 pandemic.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Am J Prev Cardiol Year: 2020 Document Type: Article Affiliation country: J.ajpc.2020.100009

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Am J Prev Cardiol Year: 2020 Document Type: Article Affiliation country: J.ajpc.2020.100009